NYSE · JHX

James Hardie Industries PLC

$26.66 +$0.12 (+0.45%) 1D After hours

Key Metrics

$15.40B
Market cap
P/E · TTM
Revenue · TTM
Net income
EPS · TTM
Dividend yield
Free cash flow $205.90M
Beta · 1Y 1.68
EBITDA · TTM
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 11
    The stock moved +8.5% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jun 11
  • May 20
    The stock moved +10.6% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 20
  • Mar 30
    From its Feb 11 high, the share price fell 32%.

    Peak close $26.00 on Feb 11; trough close $17.58 on Mar 30. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -32%

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$15.40B
Enterprise value$19.67B
Shares outstanding580.3M
52-wk range$16.46 – $29.83
Avg volume · 20D1.6M
Net cash −$4.27B
Book value / share$11.07
ExchangeNYSE
About James Hardie Industries PLC
IPO dateJul 1, 2025
Employees7500

James Hardie is a manufacturer of fiber cement-based building products, selling primarily to the residential construction industry. North America is the primary geography, generating about 80% of group earnings.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S
P/FCF74.80
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross
Operating
Net
FCF
ROE / ROIC — · —

Financial Health

Current ratio1.58
Quick ratio1.03
Debt / equity0.71
Debt / EBITDA
Net cash −$4.27B
Working capital$669.40M

Cash Flow · TTM

Operating CF $589.80M
Capex −$383.90M
Free cash flow $205.90M
Buybacks $0
Dividends paid
Shareholder yield 0.0%

Piotroski F-Score

3 / 9
Weak fundamentals · 3 of 9 signals passing

Altman Z-Score

Insufficient balance-sheet inputs

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings